Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG)

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

Citations

So far, Dimensions has found 3 publications that cite this research output.

Article in Expert Review of Anticancer Therapy (March 2022)

Article in Urologic Oncology Seminars and Original Investigations (November 2016)

Article in Cancer (November 2016)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.